Subscribe: Medscape Hematology-Oncology Headlines
http://www.medscape.com/cx/rssfeeds/2678.xml
Preview: Medscape Hematology-Oncology Headlines

Medscape Hematology-Oncology Headlines



Latest medical news, articles, and features from Medscape Hematology-Oncology



 



Imatinib a Double-Edged Sword for Pregnant CML PatientsImatinib a Double-Edged Sword for Pregnant CML Patients

Tue, 19 Sep 2017 08:20:33 EDT

On the one hand, imatinib keeps the CML in check; on the other hand, it carries a risk for fetal congenital malformation if taken during pregnancy.
Medscape Medical News



Futile: Prostate Cancer Vaccine Phase 3 Trial EndsFutile: Prostate Cancer Vaccine Phase 3 Trial Ends

Tue, 19 Sep 2017 06:17:10 EDT

Prostvac is an immunotherapy designed to induce T-cell responses and thus kill prostate cancer cells. As a monotherapy, it is not effective.
Medscape Medical News



Severe Health Problems Plague Survivors of Childhood CA Severe Health Problems Plague Survivors of Childhood CA

Mon, 18 Sep 2017 13:23:52 EDT

Specialized healthcare delivery is needed for diverse subgroups of adult cancer survivors with complex medical needs, say researchers.
Medscape Medical News



'Big Alcohol' Deliberately Downplays Cancer Risk'Big Alcohol' Deliberately Downplays Cancer Risk

Mon, 18 Sep 2017 11:25:43 EDT

Global alcohol producers are downplaying the cancer risks associated with drinking in order to protect profits, just like tobacco firms did, say public health experts.
Medscape Medical News



More Than Okay to Reduce Sorafenib Dose for Liver CancerMore Than Okay to Reduce Sorafenib Dose for Liver Cancer

Fri, 15 Sep 2017 16:06:38 EDT

Initially reducing the dosage of the oral therapy did not compromise overall survival in hepatocellular carcinoma and had important benefits.
Medscape Medical News



EU Panel Likes an Array of Cancer ProductsEU Panel Likes an Array of Cancer Products

Fri, 15 Sep 2017 13:02:12 EDT

The Committee for Medicinal Products for Human Use recommended granting marketing authorization to branded, generic, and biosimiliar products.
International Approvals



New Drug Approved for Relapsed Lymphoma: CopanlisibNew Drug Approved for Relapsed Lymphoma: Copanlisib

Thu, 14 Sep 2017 13:36:33 EDT

Patients with follicular lymphoma who have relapsed after at least two prior therapies now have a new option.
FDA Approvals



First Oncology Biosimilar Approved in US: BevacizumabFirst Oncology Biosimilar Approved in US: Bevacizumab

Thu, 14 Sep 2017 13:18:01 EDT

The FDA has approved the first biosimilar for use in the treatment of cancer: Mvasi, or bevacizumab-awwb (equivalent to Avastin).
FDA Approvals



$45 Million for Patients Harmed by Disgraced Breast Surgeon $45 Million for Patients Harmed by Disgraced Breast Surgeon

Thu, 14 Sep 2017 12:38:37 EDT

The private healthcare company that employed disgraced breast cancer surgeon Ian Paterson, who is now in jail, will pay compensation to his patients.
Medscape Medical News